105 related articles for article (PubMed ID: 9714785)
1. Mechanism of action of probucol on cholesteryl ester transfer protein (CETP) mRNA in a Chinese hamster ovary cell line that had been stably transfected with a human CETP gene.
Ou J; Saku K; Jimi S; Ohta T; Zhang B; Pownall HJ; Shimada Y; Tsujita Y; Arakawa K
Biochim Biophys Acta; 1998 Jul; 1393(1):153-60. PubMed ID: 9714785
[TBL] [Abstract][Full Text] [Related]
2. Combined effects of probucol and benzafibrate on lipoprotein metabolism and liver cholesteryl ester transfer protein mRNA in cholesterol-fed rabbits.
Ou J; Saku K; Jimi S; Liao YL; Ohta T; Zhang B; Arakawa K
Jpn Circ J; 1999 Jun; 63(6):471-7. PubMed ID: 10406588
[TBL] [Abstract][Full Text] [Related]
3. Efficient nuclear delivery of antisense oligodeoxynucleotides and selective inhibition of CETP expression by apo E peptide in a human CETP-stably transfected CHO cell line.
Liu K; Ou J; Saku K; Jimi S; Via DP; Sparrow JT; Zhang B; Pownall HJ; Smith LC; Arakawa K
Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2207-13. PubMed ID: 10479664
[TBL] [Abstract][Full Text] [Related]
4. Adipose tissue cholesteryl ester transfer protein mRNA in response to probucol treatment: cholesterol and species dependence.
Quinet EM; Huerta P; Nancoo D; Tall AR; Marcel YL; McPherson R
J Lipid Res; 1993 May; 34(5):845-52. PubMed ID: 8509722
[TBL] [Abstract][Full Text] [Related]
5. Increase in plasma cholesteryl ester transfer protein during probucol treatment. Relation to changes in high density lipoprotein composition.
McPherson R; Hogue M; Milne RW; Tall AR; Marcel YL
Arterioscler Thromb; 1991; 11(3):476-81. PubMed ID: 1903061
[TBL] [Abstract][Full Text] [Related]
6. Modulation of HDL metabolism by probucol in complete cholesteryl ester transfer protein deficiency.
Noto H; Kawamura M; Hashimoto Y; Satoh H; Hara M; Iso-o N; Togo M; Kimura S; Tsukamoto K
Atherosclerosis; 2003 Nov; 171(1):131-6. PubMed ID: 14642415
[TBL] [Abstract][Full Text] [Related]
7. Probucol increases cholesteryl ester transfer protein activity in hypercholesterolaemic patients.
Franceschini G; Chiesa G; Sirtori CR
Eur J Clin Invest; 1991 Aug; 21(4):384-8. PubMed ID: 1936105
[TBL] [Abstract][Full Text] [Related]
8. High-density lipoproteins from probucol-treated patients have increased capacity to promote cholesterol efflux from mouse peritoneal macrophages loaded with acetylated low-density lipoproteins.
Ishigami M; Yamashita S; Sakai N; Hirano K; Arai T; Maruyama T; Takami S; Koyama M; Kameda-Takemura K; Matsuzawa Y
Eur J Clin Invest; 1997 Apr; 27(4):285-92. PubMed ID: 9134376
[TBL] [Abstract][Full Text] [Related]
9. Probucol normalizes cholesteryl ester transfer in IDDM.
Bagdade JD; Stein E; Ritter MC
Diabetes Care; 1995 Oct; 18(10):1341-6. PubMed ID: 8721935
[TBL] [Abstract][Full Text] [Related]
10. Opposite effects on serum cholesteryl ester transfer protein levels between long-term treatments with pravastatin and probucol in patients with primary hypercholesterolemia and xanthoma.
Inazu A; Koizumi J; Kajinami K; Kiyohar T; Chichibu K; Mabuchi H
Atherosclerosis; 1999 Aug; 145(2):405-13. PubMed ID: 10488970
[TBL] [Abstract][Full Text] [Related]
11. Profound induction of hepatic cholesteryl ester transfer protein transgene expression in apolipoprotein E and low density lipoprotein receptor gene knockout mice. A novel mechanism signals changes in plasma cholesterol levels.
Masucci-Magoulas L; Plump A; Jiang XC; Walsh A; Breslow JL; Tall AR
J Clin Invest; 1996 Jan; 97(1):154-61. PubMed ID: 8550828
[TBL] [Abstract][Full Text] [Related]
12. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
Artery; 1993; 20(1):1-18. PubMed ID: 8447724
[TBL] [Abstract][Full Text] [Related]
13. A hyperalphalipoproteinaemic family with normal cholesteryl ester transfer/exchange activity.
Groener JE; da Col PG; Kostner GM
Biochem J; 1987 Feb; 242(1):27-31. PubMed ID: 3593240
[TBL] [Abstract][Full Text] [Related]
14. Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice.
Masucci-Magoulas L; Moulin P; Jiang XC; Richardson H; Walsh A; Breslow JL; Tall A
J Clin Invest; 1995 Apr; 95(4):1587-94. PubMed ID: 7706465
[TBL] [Abstract][Full Text] [Related]
15. Scavenger receptor type BI potentiates reverse cholesterol transport system by removing cholesterol ester from HDL.
Kinoshita M; Fujita M; Usui S; Maeda Y; Kudo M; Hirota D; Suda T; Taki M; Okazaki M; Teramoto T
Atherosclerosis; 2004 Apr; 173(2):197-202. PubMed ID: 15064092
[TBL] [Abstract][Full Text] [Related]
16. Endotoxin and cytokines decrease serum levels and extra hepatic protein and mRNA levels of cholesteryl ester transfer protein in syrian hamsters.
Hardardóttir I; Moser AH; Fuller J; Fielding C; Feingold K; Grünfeld C
J Clin Invest; 1996 Jun; 97(11):2585-92. PubMed ID: 8647952
[TBL] [Abstract][Full Text] [Related]
17. An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels.
Hayek T; Chajek-Shaul T; Walsh A; Agellon LB; Moulin P; Tall AR; Breslow JL
J Clin Invest; 1992 Aug; 90(2):505-10. PubMed ID: 1644921
[TBL] [Abstract][Full Text] [Related]
18. Probucol normalizes cholesteryl ester transfer in type 2 diabetes.
Bagdade JD; Lane JT; Subbaiah PV
Diabetes Res Clin Pract; 2016 Jun; 116():29-35. PubMed ID: 27321313
[TBL] [Abstract][Full Text] [Related]
19. Dual effects on HDL metabolism by cholesteryl ester transfer protein inhibition in HepG2 cells.
Huang Z; Inazu A; Kawashiri MA; Nohara A; Higashikata T; Mabuchi H
Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1210-9. PubMed ID: 12604506
[TBL] [Abstract][Full Text] [Related]
20. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
Berti JA; Amaral ME; Boschero AC; Nunes VS; Harada LM; Castilho LN; Oliveira HC
Metabolism; 2001 May; 50(5):530-6. PubMed ID: 11319713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
